supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago
supplement:
Vadimezan
Research Papers that Mention the Interaction
“The tumor vascular‐disrupting agent (VDA) vadimezan 5,6‐dimethylxanthenone‐4‐acetic acid , DMXAA) has been shown to potentiate the antitumor activity of photodynamic therapy (PDT) using systemically administered photosensitizers.”
Aminolevulinic Acid‐Photodynamic Therapy Combined with Topically Applied Vascular Disrupting Agent Vadimezan Leads to Enhanced Antitumor Responses
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback